DAFTAR PUSTAKA

Al-Dhabi, Naif A., Basheer A. Al-Sum., Rayed F. Al-Hammad. Molecular

epidemiology of Mycobacterium species clinical isolates in Riyadh, Saudi

Arabia. Life Science Journal. 2013;10(4).1551-1556

Alfian, S.D., E.S. Tarigan., I. M. Puspitasari., R. Abdulah. Profil Penggunaan

Antituberkulosis di Apotek di Kota Bandung Periode 2008–2010. Jurnal

Farmasi Klinik Indonesia. Vol. 01 No 4 Desember 2012.

Bates Michael N., Khalakdina A., Pai M., Chang L., Lessa F., Smith K., et al.

Risk of Tuberculosis From Exposure to Tobacco Smoke, Arch Intern Med.

2007; 167(4): 335-42.

Danusantoso, H. 2000. Buku Saku Ilmu Penyakit Paru, Edisi Ke 1. Jakarta:

Penerbit Hipokrates.

Departemen Kesehatan RI, 2005. Pharmaceutical Care untuk Penyakit

Tuberkulosis. Jakarta: Kementerian Kesehatan RI.

Curry, F.J. 2004. National Tuberculosis Center. Drug Resistant Tuberculosis, a

Survivalguide for clinicians. California,2004 p 1-15

Hutchinson, J.M., Patrick, D.M., Marra, F., Ng, H., Bowie, W.R., Heule, L.,

Muscat, M. & Monnet, D.L. (2004) Measurement Of Antibiotic

Consumption: A Practical Guide To The Use Of The Anatomical

Therapeutic Chemical Classification And Defined Daily Dose System

Methodology In Canada. Canadian Journal Of Infectious Diseases 15, 29-

35. Diakses Pada 08 November 2014.

Istiantoro., Yati H., R. Setiabudy. 2009. Farmakologi dan Terapi Edisi V:

Tuberkulostatik dan Leprostatik. Jakarta: Fakultas Kedokteran Universitas

Indonesia.

Jnawali, Hum Nath and Sungweon Ryoo (2013). First– and Second–Line Drugs

and Drug Resistance, Tuberculosis - Current Issues in Diagnosis and

Management, Dr. Bassam Mahboub (Ed.), ISBN: 978-953-51-1049-1,

InTech, DOI: 10.5772/54960. Available from:

http://www.intechopen.com/books/tuberculosis-current-issues-in-

diagnosis-and-management/first-and-second-line-drugs-and-drug-

resistance